Eli Shefter

Title: Eli Shefter: Innovator in Graft Treatment Technology

Introduction

Eli Shefter is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of transplantation through his innovative methods. His work focuses on improving the success rates of grafts used in medical procedures.

Latest Patents

Eli Shefter holds a patent for a method for the treatment of grafts prior to transplantation using TGF-.beta. This method involves incubating, coating, or perfusing grafts such as tissues or organs with TGF-.beta for an effective duration. The goal is to enhance the uptake of the agent into the grafts and induce its biological effects. The treated graft is then transplanted into a compatible host, preferably a human.

Career Highlights

Eli Shefter is currently employed at Genentech, Inc., a leading biotechnology company. His work there has allowed him to focus on groundbreaking research and development in the field of graft treatments. His innovative approach has the potential to significantly improve patient outcomes in transplantation.

Collaborations

Eli has collaborated with esteemed colleagues, including Christine W Czarniecki and Michael A Palladino. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Eli Shefter's contributions to graft treatment technology exemplify the impact of innovation in medicine. His patent and work at Genentech, Inc. highlight his commitment to improving transplantation outcomes. Eli's efforts continue to pave the way for advancements in medical science.